Pancreatic Cancer Drug Trial Planned For Canada
An experimental pancreatic cancer drug, daraxonrasib, which doubled survival rates in a US-led study, may undergo clinical trials in Canada. Medical oncologist Dr. Jennifer Knox reviewed the study and called it promising.
Topics
Developing
- 884d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 884d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 884d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 884d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Pancreatic cancer pill that doubled survival may get Canada clinical trialMedical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls t...”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade